84 related articles for article (PubMed ID: 3972760)
21. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
[TBL] [Abstract][Full Text] [Related]
22. Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.
Gomis M; Herranz A; Aparicio P; Filloy JL; Pastor J
J Antimicrob Chemother; 1990 Sep; 26 Suppl A():45-52. PubMed ID: 2228844
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of imipenem in severe infections.
Baumgartner JD; Glauser MP
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():141-8. PubMed ID: 6321426
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.
Schleupner CJ
Infection; 1985; 13 Suppl 1():S28-33. PubMed ID: 4055051
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience of cefotaxime in infections caused by gram-positive pathogens.
Bassetti D; Solbiati M; Fraizzoli G
Infection; 1985; 13 Suppl 1():S112-4. PubMed ID: 4055040
[TBL] [Abstract][Full Text] [Related]
26. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
Plosker GL; Foster RH; Benfield P
Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
[TBL] [Abstract][Full Text] [Related]
27. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
Jauregui L; Minns P; Hageage G
J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
[TBL] [Abstract][Full Text] [Related]
28. [The use of cefotaxime against infections (author's transl)].
Lepeu G; Bertrand A; Armengaud M; Aubertin J
Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
Yangco BG; Baird I; Lorber B; Noble R; Bermudez R; Silverblatt F; Vasquez G
J Antimicrob Chemother; 1987 Feb; 19(2):239-48. PubMed ID: 3553135
[TBL] [Abstract][Full Text] [Related]
30. Ceftriaxone in the treatment of serious infections, particularly after surgery.
Scully BE; Neu HC
Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
[TBL] [Abstract][Full Text] [Related]
31. [A clinical study of cefotaxime in patients with infections complicating a disorder of the hemopoietic tissue. Its therapeutic effect and influence on the coagulation system].
Kaneko H; Shirai T; Katoh M; Shimura H; Nojima Z; Senzui N
Jpn J Antibiot; 1985 Nov; 38(11):3145-55. PubMed ID: 4094050
[TBL] [Abstract][Full Text] [Related]
32. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
[TBL] [Abstract][Full Text] [Related]
33. Cefotaxime (HR-756) in urinary tract infections.
Paradisi F; Cristiano P; Mirone V; D'Armiento V; Iovene MR
Chemotherapy; 1982; 28(1):64-9. PubMed ID: 6276110
[TBL] [Abstract][Full Text] [Related]
34. A therapeutic trial of cefotaxime versus penicillin-gentamicin for severe infections in children.
Haffejee IE
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():147-52. PubMed ID: 6094434
[TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of cefotaxime in pediatric infectious diseases].
Takimoto M; Tasaki T; Kusunoki Y; Yoshioka H; Hiramoto A; Sanae N; Tsuchida A; Maruyama S; Mukai N; Takahashi Y
Jpn J Antibiot; 1985 Jan; 38(1):107-13. PubMed ID: 3989970
[TBL] [Abstract][Full Text] [Related]
36. Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients.
de Pauw BE; Kauw F; Muytjens H; Williams KJ; Bothof T
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():93-9. PubMed ID: 6311790
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with ticarcillin and sulfamethoxazole-trimethoprim for infections in patients with cancer.
Keating MJ; Lawson R; Grose W; Bodey GP
Arch Intern Med; 1981 Jun; 141(7):926-30. PubMed ID: 7235813
[TBL] [Abstract][Full Text] [Related]
38. Ceftizoxime treatment of infection in neutropenic patients with malignancies.
Lawson RD; Baskin RC
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():159-65. PubMed ID: 6296001
[No Abstract] [Full Text] [Related]
39. [Clinical effects of ceftizoxime and latamoxef on infections in acute leukemia].
Kohi F; Ohmoto E; Endo Y; Oda Y; Fujimoto S; Uchida K; Takaoka K; Hara M; Lai M; Takahashi I
Jpn J Antibiot; 1983 Jul; 36(7):1645-52. PubMed ID: 6317909
[TBL] [Abstract][Full Text] [Related]
40. [Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
Sampi K; Kumai R; Sakurai M; Kaneko Y; Hattori M
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1301-5. PubMed ID: 4004291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
